Inventor
THOMSON DAVID S
US43 patents
⚠️ This page may combine multiple inventors who share the name “THOMSON DAVID S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BOEHRINGER INGELHEIM PHARMA
27 patentsUS6903215B2Jun 7, 2005
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
BOEHRINGER INGELHEIM PHARMA51 citations95
US6420364B1Jul 16, 2002
Compound useful as reversible inhibitors of cysteine proteases
BOEHRINGER INGELHEIM PHARMA59 citations95
US7279472B2Oct 9, 2007
Compounds useful as reversible inhibitors of cysteine proteases
BOEHRINGER INGELHEIM PHARMA10 citations92
US6858627B2Feb 22, 2005
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
BOEHRINGER INGELHEIM PHARMA50 citations92
US6525052B2Feb 25, 2003
Compounds useful as reversible inhibitors of cysteine proteases
BOEHRINGER INGELHEIM PHARMA17 citations92
US6313117B1Nov 6, 2001
Succinate derivative compounds useful as cysteine protease inhibitors
BOEHRINGER INGELHEIM PHARMA39 citations92
US7553966B2Jun 30, 2009
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
BOEHRINGER INGELHEIM PHARMA19 citations91
US7268152B2Sep 11, 2007
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
BOEHRINGER INGELHEIM PHARMA24 citations91
US6960581B2Nov 1, 2005
Glucocorticoid mimetics, methods of making them, pharmaceutical formulations, and uses thereof
BOEHRINGER INGELHEIM PHARMA41 citations91
US6730671B2May 4, 2004
Compounds useful as reversible inhibitors of cathespin S
BOEHRINGER INGELHEIM PHARMA26 citations91
US6720319B2Apr 13, 2004
Compounds useful as reversible inhibitors of cysteine proteases
BOEHRINGER INGELHEIM PHARMA19 citations91
US6395897B1May 28, 2002
Nitrile compounds useful as reversible inhibitors of #9 cathepsin 5
BOEHRINGER INGELHEIM PHARMA28 citations91
US7932392B2Apr 26, 2011
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
BOEHRINGER INGELHEIM PHARMA8 citations83
US7741361B2Jun 22, 2010
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
BOEHRINGER INGELHEIM PHARMA13 citations83
US7635711B2Dec 22, 2009
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
BOEHRINGER INGELHEIM PHARMA15 citations83
US7579469B2Aug 25, 2009
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
BOEHRINGER INGELHEIM PHARMA15 citations83
US7622594B2Nov 24, 2009
Glucocortioid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
BOEHRINGER INGELHEIM PHARMA16 citations81
US6858623B2Feb 22, 2005
Compounds useful as reversible inhibitors of cysteine proteases
BOEHRINGER INGELHEIM PHARMA9 citations81
US7056915B2Jun 6, 2006
Compounds useful as reversible inhibitors of cysteine proteases
BOEHRINGER INGELHEIM PHARMA3 citations73
US6982272B2Jan 3, 2006
Compounds useful as reversible inhibitors of cysteine proteases
BOEHRINGER INGELHEIM PHARMA6 citations73
US6756372B2Jun 29, 2004
Compounds useful as reversible inhibitors of cysteine proteases
BOEHRINGER INGELHEIM PHARMA6 citations73
US6608057B2Aug 19, 2003
Compounds useful as reversible inhibitors of cathepsin S
BOEHRINGER INGELHEIM PHARMA9 citations72
US6649642B2Nov 18, 2003
Succinate derivative compounds useful as cysteine protease inhibitors
BOEHRINGER INGELHEIM PHARMA7 citations63
US6936606B2Aug 30, 2005
Cyanoamido-containing heterocyclic compounds useful as reversible inhibitors of cysteine proteases
BOEHRINGER INGELHEIM PHARMA7 citations62
US6787540B2Sep 7, 2004
Compounds useful as reversible inhibitors of cysteine proteases
BOEHRINGER INGELHEIM PHARMA2 citations62
US7265132B2Sep 4, 2007
Compounds useful as reversible inhibitors of cysteine proteases
BOEHRINGER INGELHEIM PHARMA0 citations51
US6982263B2Jan 3, 2006
Nitriles useful as reversible inhibitors of cysteine proteases
BOEHRINGER INGELHEIM PHARMA2 citations51
ICI PLC
5 patentsUS4587262AMay 6, 1986
Halogenophenyl glyceride esters for use in the prophylaxis and/or therapy of acne vulgaris
ICI PLC14 citations73
US4764361AAug 16, 1988
Pharmaceutical compositions
ICI PLC15 citations66
US4568691AFeb 4, 1986
Anti-inflammatory esters of 4-(1-hydroxy-2-[(acylamino)-alkylamino]-ethyl)-phenol derivatives, compositions, and method of use therefor
ICI PLC2 citations61
US4470997ASep 11, 1984
Esters
ICI PLC0 citations52
US4520027AMay 28, 1985
Anti-inflammatory esters of 4-(1-hydroxy-2-[(acylamino)alkylamino]ethyl) phenols
ICI PLC0 citations51
GREENWICH PHARMA
3 patentsUS5360792ANov 1, 1994
Anti-proliferative and anti-inflammatory compounds: 5- or 6-deoxy hexose monosaccharides having a saturated nitrogen-containing heterocycle at the 5- or 6-position bound through the nitrogen atom
GREENWICH PHARMA9 citations70
US5432163AJul 11, 1995
Anti-proliferative and anti-inflammatory compounds: derivatives of pentose monosaccharides
GREENWICH PHARMA6 citations54
US6060453AMay 9, 2000
Immunomodulatory, anti-inflammatory, and anti-proliferative compounds: 5,6-dideoxy, 5-amino derivatives of idose and 6-deoxy, 6-amino derivatives of glucose
GREENWICH PHARMA6 citations51